Low expression of ASH2L protein correlates with a favorable outcome in acute myeloid leukemia

References

• Butler JS, Dent SY. The role of chromatin modifiers in normal and malignant hematopoiesis. Blood. 2013;121:3076–3084.
   PubMed Web of Science ®Google Scholar
• Milne TA, Briggs SD, Brock HW, et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell. 2002;10:1107–1117.
   PubMed Web of Science ®Google Scholar
• Ziemin-van der Poel S, McCabe NR, Gill HJ, et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA. 1991;88:10735–10739.
   PubMed Web of Science ®Google Scholar
• Tkachuk DC, Kohler S, Cleary ML. Involvement of a homolog of Drosophila Trithorax by 11q23 chromosomal translocations in acute leukemias. Cell. 1992;71:691–700.
   PubMed Web of Science ®Google Scholar
• Chen CS, Sorensen PH, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood. 1993;81:2386–2393.
   PubMed Web of Science ®Google Scholar
• Dou Y, Milne TA, Ruthenburg AJ, et al. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol. 2006;13:713–719.
   PubMed Web of Science ®Google Scholar
• Steward MM, Lee JS, O'Donovan A, et al. Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat Struct Mol Biol. 2006;13:852–854.
   PubMed Web of Science ®Google Scholar
• Patel A, Dharmarajan V, Vought VE, et al. On the mechanism of multiple lysine methylation by the human mixed lineage leukemia protein-1 (MLL1) core complex. J Biol Chem. 2009;284:24242–24256.
   PubMed Web of Science ®Google Scholar
• Yang Z, Augustin J, Hu J, et al. Physical interactions and functional coordination between the core subunits of set1/Mll complexes and the reprogramming factors. PLoS One. 2015;10:e0145336. doi: 10.1371/journal.pone.0145336.
   Google Scholar
• Tan CC, Sindhu KV, Li S, et al. Transcription factor Ap2delta associates with Ash2l and ALR, a trithorax family histone methyltransferase, to activate Hoxc8 transcription. Proc Natl Acad Sci USA. 2008;105:7472–7477.
   PubMed Web of Science ®Google Scholar
• Ikegawa S, Isomura M, Koshizuka Y, et al. Cloning and characterization of ASH2L and Ash2l, human and mouse homologs of the Drosophila ash2 gene. Cytogenet Cell Genet. 1999;84:167–172.
   PubMedGoogle Scholar
• Stoller JZ, Huang L, Tan CC, et al. Ash2l interacts with Tbx1 and is required during early embryogenesis. Exp Biol Med (Maywood). 2010;235:569–576.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou Y, Yin B, et al. ASH2L: alternative splicing and downregulation during induced megakaryocytic differentiation of multipotential leukemia cell lines. J Mol Med (Berl). 2001;79:399–405.
   PubMed Web of Science ®Google Scholar
• Demers C, Chaturvedi CP, Ranish JA, et al. Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. Mol Cell. 2007;27:573–584.
   PubMed Web of Science ®Google Scholar
• Zhang P, Chaturvedi CP, Tremblay V, et al. A phosphorylation switch on RbBP5 regulates histone H3 Lys4 methylation. Genes Dev. 2015;29:123–128.
   PubMed Web of Science ®Google Scholar
• Luscher-Firzlaff J, Gawlista I, Vervoorts J, et al. The human trithorax protein hASH2 functions as an oncoprotein. Cancer Res. 2008;68:749–758.
   PubMed Web of Science ®Google Scholar
• Ullius A, Luscher-Firzlaff J, Costa IG, et al. The interaction of MYC with the trithorax protein ASH2L promotes gene transcription by regulating H3K27 modification. Nucleic Acids Res. 2014;42:6901–6920.
   PubMed Web of Science ®Google Scholar
• Butler JS, Zurita-Lopez CI, Clarke SG, et al. Protein-arginine methyltransferase 1 (PRMT1) methylates ASH2L, a shared component of mammalian histone H3K4 methyltransferase complexes. J Biol Chem. 2011;286:12234–12244.
   PubMed Web of Science ®Google Scholar
• Chang YI, Hua WK, Yao CL, et al. Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells. J Biol Chem. 2010;285:20595–20606.
   PubMed Web of Science ®Google Scholar
• Cheung N, Chan LC, Thompson A, et al. Protein arginine-methyltransferase-dependent oncogenesis. Nat Cell Biol. 2007;9:1208–1215.
   PubMed Web of Science ®Google Scholar
• Wang L, Pal S, Sif S. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells. Mol Cell Biol. 2008;28:6262–6277.
   PubMed Web of Science ®Google Scholar
• Kornblau SM, Singh N, Qiu Y, et al. Highly phosphorylated FOXO3A is an adverse prognostic factor in acute myeloid leukemia. Clin Cancer Res. 2010;16:1865–1874.
   PubMed Web of Science ®Google Scholar
• Kornblau SM, Qiu YH, Zhang N, et al. Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood. 2011;118:5604–5612.
   PubMed Web of Science ®Google Scholar
• Kornblau SM, Coombes KR. Use of reverse phase protein microarrays to study protein expression in leukemia: technical and methodological lessons learned. Methods Mol Biol. 2011;785:141–155.
   PubMedGoogle Scholar
• Tibes R, Qiu Y, Lu Y, et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ther. 2006;5:2512–2521.
   PubMed Web of Science ®Google Scholar
• Ortega A, Niksic M, Bachi A, et al. Biochemical function of female-lethal (2)D/Wilms' tumor suppressor-1-associated proteins in alternative pre-mRNA splicing. J Biol Chem. 2003;278:3040–3047.
   PubMed Web of Science ®Google Scholar
• Venables JP, Koh CS, Froehlich U, et al. Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol Cell Biol. 2008;28:6033–6043.
   PubMed Web of Science ®Google Scholar
• Stirewalt DL, Radich JP. The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer. 2003;3:650–665.
   PubMed Web of Science ®Google Scholar
• Smith CC, Wang Q, Chin CS, et al. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature. 2012;485:260–263.
   PubMed Web of Science ®Google Scholar
• Lindstrom MS. NPM1/B23: a multifunctional chaperone in ribosome biogenesis and chromatin remodeling. Biochem Res Int. 2011;2011:195209. doi: 10.1155/2011/195209.
   PubMedGoogle Scholar
• Okuwaki M, Matsumoto K, Tsujimoto M, et al. Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone. FEBS Lett. 2001;506:272–276.
   PubMed Web of Science ®Google Scholar
• Murano K, Okuwaki M, Hisaoka M, et al. Transcription regulation of the rRNA gene by a multifunctional nucleolar protein, B23/nucleophosmin, through its histone chaperone activity. Mol Cell Biol. 2008;28:3114–3126.
   PubMed Web of Science ®Google Scholar
• Falini B, Gionfriddo I, Cecchetti F, et al. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?. Blood Rev. 2011;25:247–254.
   PubMed Web of Science ®Google Scholar
• Greer EL, Maures TJ, Hauswirth AG, et al. Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans. Nature. 2010;466:383–387.
   PubMed Web of Science ®Google Scholar
• Greer EL, Maures TJ, Ucar D, et al. Transgenerational epigenetic inheritance of longevity in Caenorhabditis elegans. Nature. 2011;479:365–371.
   PubMed Web of Science ®Google Scholar
• Ali A, Veeranki SN, Tyagi S. A SET-domain-independent role of WRAD complex in cell-cycle regulatory function of mixed lineage leukemia. Nucleic Acids Res. 2014;42:7611–7624.
   PubMed Web of Science ®Google Scholar
• Guertin DA, Guntur KV, Bell GW, et al. Functional genomics identifies TOR-regulated genes that control growth and division. Curr Biol. 2006;16:958–970.
   PubMed Web of Science ®Google Scholar
• Bomsztyk K, Denisenko O, Ostrowski J. hnRNP K: one protein multiple processes. Bioessays. 2004;26:629–638.
   PubMed Web of Science ®Google Scholar
• Bansal H, Yihua Q, Iyer SP, et al. WTAP is a novel oncogenic protein in acute myeloid leukemia. Leukemia. 2014;28:1171–1174.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wan B, Wang KC, et al. Crystal structure of the N-terminal region of human ASH2L shows a winged-helix motif involved in DNA binding. EMBO Rep. 2011;12:797–803.
   PubMed Web of Science ®Google Scholar
• Sarvan S, Avdic V, Tremblay V, et al. Crystal structure of the trithorax group protein ASH2L reveals a forkhead-like DNA binding domain. Nat Struct Mol Biol. 2011;18:857–859.
   PubMed Web of Science ®Google Scholar
• Chang YI, Hsu SC, Chau GY, et al. Identification of the methylation preference region in heterogeneous nuclear ribonucleoprotein K by protein arginine methyltransferase 1 and its implication in regulating nuclear/cytoplasmic distribution. Biochem Biophys Res Commun. 2011;404:865–869.
   PubMed Web of Science ®Google Scholar
• Ostareck-Lederer A, Ostareck DH, Rucknagel KP, et al. Asymmetric arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-arginine methyltransferase 1 inhibits its interaction with c-Src. J Biol Chem. 2006;281:11115–11125.
   PubMed Web of Science ®Google Scholar
• Briggs SD, Bryk M, Strahl BD, et al. Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae. Genes Dev. 2001;15:3286–3295.
   PubMed Web of Science ®Google Scholar
• Bryk M, Briggs SD, Strahl BD, et al. Evidence that Set1, a factor required for methylation of histone H3, regulates rDNA silencing in S. cerevisiae by a Sir2-independent mechanism. Curr Biol. 2002;12:165–170.
   PubMed Web of Science ®Google Scholar
• Fingerman IM, Wu CL, Wilson BD, et al. Global loss of Set1-mediated H3 Lys4 trimethylation is associated with silencing defects in Saccharomyces cerevisiae. J Biol Chem. 2005;280:28761–28765.
   PubMed Web of Science ®Google Scholar
• Falini B, Martelli MP, Bolli N, et al. Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?. Blood. 2011;117:1109–1120.
   PubMed Web of Science ®Google Scholar
• Falini B, Bolli N, Liso A, et al. Altered nucleophosmin transport in acute myeloid leukemia with mutated NPM1: molecular basis and clinical implications. Leukemia. 2009;23:1731–1743.
   PubMed Web of Science ®Google Scholar